Propiedad y actividad de insiders de BioAtla, Inc. (BCAB): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $1.74 |
| Capitalización | $3M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $10.9M | $3.7M | $238.6M | $245.0M | $215.5M | $111.5M | $49.0M | $7.1M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $12.7M | $4.5M | $240.7M | $247.3M | $220.4M | $116.4M | $51.2M | $8.0M |
| Inmovilizado Material | $3.9M | $4.7M | $4.1M | $7.0M | $5.2M | $3.1M | $1.2M | $5.7M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $16.6M | $9.3M | $244.9M | $254.4M | $225.7M | $119.7M | $52.4M | $13.8M |
| Cuentas por Pagar | $2.0M | $5.1M | $2.5M | $1.2M | $4.2M | $3.8M | $1.9M | $8.2M |
| Deuda a Corto | 0 | $9.7M | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $9.2M | $26.7M | $32.3M | $19.8M | $23.1M | $28.3M | $14.5M | $21.9M |
| Deuda a Largo | $15.0M | $8.4M | $682000 | 0 | 0 | 0 | 0 | $4.8M |
| Pasivos Totales | $45.1M | $65.3M | $35.0M | $43.6M | $45.4M | $49.0M | $38.2M | $50.0M |
| Reservas | -$118.6M | -$148.4M | -$90.9M | -$186.3M | -$292.8M | -$416.3M | -$486.0M | -$545.6M |
| Patrimonio Neto | -$28.5M | -$56.0M | $210.0M | $210.8M | $180.3M | $70.7M | $14.3M | -$36.2M |
| Deuda Total | $15.0M | $18.1M | $682000 | $5.4M | $4.0M | $2.5M | $836000 | $6.2M |
| Deuda Neta | $4.1M | $14.4M | -$237.9M | -$239.6M | -$211.5M | -$109.0M | -$48.2M | -$918000 |
| Capital Circulante | $3.5M | -$22.2M | $208.4M | $227.5M | $197.3M | $88.1M | $36.7M | -$13.9M |
Salud financiera
| Deuda / Patrimonio | -0.16 |
| Ratio corriente | 0.20 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -70.06 |
Rentabilidad
| Rentabilidad sobre capital | 89.25% |
| Rentabilidad sobre capital invertido | 318.00% |
| Rentabilidad sobre activos | -330.89% |
| Margen bruto | -4.15% |
| Margen operativo | -372.06% |
| Margen neto | -370.05% |
Empresas relacionadas: ANVS · BTAI · CELU · EVAX · GBIO · MRSN · MURA
Explorar sector: Healthcare · Biotechnology
Más secciones de BCAB: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones